Pharmacokinetic, bioavaiability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man - Fucella, L. M; Corvi, G; Moro, E; Pogliani, E; Tamassia, V; Tosolini, G (Europ. J. clin. Pharmacol, 1979)